Sergio De Filippis

Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)

Giovanni Martinotti, Antonio Vita, Andrea Fagiolini et al. · Journal of Affective Disorders · 2022 · 115 citations

Esketamine Use, Psychiatry, Real-world Experience +10

Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar <scp>treatment‐resistant</scp> depression

Giovanni Martinotti, Bernardo Dell’Osso, Giorgio Di Lorenzo et al. · Bipolar Disorders · 2023 · 68 citations · Full text

Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine

Francesca Romana Patacchioli, Paola Monnazzi, S. Simeoni et al. · The Journal of Headache and Pain · 2006 · 59 citations · Full text

Social Sciences, Medication Overuse Headache, Neuroendocrine Mechanism +20

Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life

Ilaria Cuomo, Georgios D. Kotzalidis, Simone De Persis et al. · Neuropsychiatric Disease and Treatment · 2018 · 55 citations · Full text

Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)

Mauro Pettorruso, Roberto Guidotti, Giacomo d’Andrea et al. · Psychiatry Research · 2023 · 49 citations · Full text